H1 2026 report
Diagnostyka to lider polskiego rynku diagnostyki laboratoryjnej i obrazowej, rosnący dwucyfrowo (przychody +14,8% r/r do 1,35 mld zł w I półroczu 2026 r.), napędzany głównie wzrostem cen (+11,9% r/r).
Sentiment
●●●●●●
DIA
H1 2026 report
Revenue
1.18 bn PLN
— YoY
Net income
136.67 m PLN
— YoY
EBITDA
312.23 m PLN
— YoY
FCF
225.05 m PLN
— YoY
Summary
Investment thesis
- Grupa konsekwentnie konsoliduje rozdrobniony rynek poprzez selektywne akwizycje (11 w I półroczu 2026 r., kolejna po dniu bilansowym) finansowane głównie długiem, bez odpisów z tytułu utraty wartości goodwill.
- Marża EBITDA skurczyła się o 1,8 pp r/r (do 24,7%) - koszty świadczeń pracowniczych (+15,0% r/r) i amortyzacja (+19,2% r/r) rosną szybciej niż przychody.
- Dźwignia finansowa rośnie - dług odsetkowy (kredyty+leasing) wzrósł z 1 080,6 mln zł do 1 221,5 mln zł w pół roku, dług/kapitał własny 2,32x, przy jednoczesnej wypłacie dywidendy 148,5 mln zł (4,40 zł/akcję) w czerwcu 2026 r.
- Jakość zysku pozostaje wysoka (OCF 262,9 mln zł istotnie przewyższa zysk netto 146,4 mln zł), a Zarząd potwierdza brak naruszenia kowenantów kredytowych mimo rosnącego zadłużenia.
Read the full analysis
Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.
Financials
BETA
DIA · H1 2026
| Metric | H1 2026 | H1 2025 | Δ YoY | YTD 2026 | Δ YoY | Value type | Segment | Conf. |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,179.86 | — | — | 1,179.86 | — | reported | — | 1.00 |
| EBITDA | 312.23 | — | — | 312.23 | — | derived | — | 0.90 |
| EBIT | 215.03 | — | — | 215.03 | — | reported | — | 1.00 |
| EBT | 187.28 | — | — | 187.28 | — | reported | — | 1.00 |
| Net income | 136.67 | — | — | 136.67 | — | reported | — | 1.00 |
| EPS (basic) (PLN) | 4.05 | — | — | 4.05 | — | reported | — | 1.00 |
| EPS (diluted) (PLN) | 4.15 | — | — | 4.15 | — | reported | — | 1.00 |
| D&A | 115.86 | — | — | 115.86 | — | reported | — | 1.00 |
| Interest expense | 32.89 | — | — | 32.89 | — | reported | — | 1.00 |
| Income tax | 40.9 | — | — | 40.9 | — | reported | — | 1.00 |
| Shares (basic) (m units) | 33.76 | — | — | — | — | reported | — | 1.00 |
| EBITDA margin | 26.46% | — | — | 26.46% | — | reported | — | 0.90 |
| EBIT margin | 18.22% | — | — | 18.22% | — | reported | — | 0.95 |
| Net margin | 11.58% | — | — | 11.58% | — | reported | — | 0.95 |
| Cash | 18.42 | — | — | — | — | reported | — | 1.00 |
| Total debt | 1,080.64 | — | — | — | — | reported | — | 0.95 |
| Net debt | 1,203.95 | — | — | — | — | reported | — | 0.90 |
| Equity | 547.19 | — | — | — | — | reported | — | 1.00 |
| Total assets | 2,231.88 | — | — | — | — | reported | — | 1.00 |
| Working capital | -103.55 | — | — | — | — | derived | — | 0.95 |
| Current assets | 455.78 | — | — | — | — | reported | — | 1.00 |
| Current liabilities | 559.32 | — | — | — | — | reported | — | 1.00 |
| Non-current liabilities | 1,145.24 | — | — | — | — | reported | — | 1.00 |
| Inventory | 57.99 | — | — | — | — | reported | — | 1.00 |
| Trade receivables | 345.84 | — | — | — | — | reported | — | 1.00 |
| Trade payables | 160.36 | — | — | — | — | reported | — | 1.00 |
| Goodwill | 652.67 | — | — | — | — | reported | — | 0.90 |
| CFO | 295.1 | — | — | 295.1 | — | reported | — | 1.00 |
| CapEx | 70.05 | — | — | 70.05 | — | reported | — | 1.00 |
| FCF | 225.05 | — | — | 225.05 | — | derived | — | 0.90 |
| Dividends paid | 111.73 | — | — | 111.73 | — | reported | — | 1.00 |
| Net acquisitions | 41.08 | — | — | 41.08 | — | reported | — | 0.90 |
| Current ratio | 0.81x | — | — | — | — | reported | — | 0.95 |
| Quick ratio | 0.71x | — | — | — | — | reported | — | 0.90 |
| Cash ratio | 0.03x | — | — | — | — | reported | — | 0.90 |
| Interest coverage | 6.63x | — | — | — | — | reported | — | 0.85 |
| Debt / equity | 2.32x | — | — | — | — | reported | — | 0.90 |
| Debt / assets | 0.55x | — | — | — | — | reported | — | 0.90 |
| Net debt / equity | 2.28x | — | — | — | — | reported | — | 0.90 |
| Revenue growth (YoY) | 14.75% | — | — | — | — | reported | — | 0.98 |
| EBITDA growth (YoY) | 6.97% | — | — | — | — | reported | — | 0.90 |
| EBIT growth (YoY) | 1.45% | — | — | — | — | reported | — | 0.95 |
| Net income growth (YoY) | 2.4% | — | — | — | — | reported | — | 0.95 |
| EPS growth (YoY) | 2.47% | — | — | — | — | reported | — | 0.95 |
| EBITDA margin Δ (YoY) | -1.79 pp | — | — | — | — | reported | — | 0.90 |
| EBIT margin Δ (YoY) | -2.11 pp | — | — | — | — | reported | — | 0.95 |
| Net margin Δ (YoY) | -1.24 pp | — | — | — | — | reported | — | 0.95 |
H1 2026 · Δ YoY
Revenue
1,179.86
—
1,179.86
—
- H1 2025
- —
- YTD 2026
- 1,179.86
- Δ YoY
- —
EBITDA
312.23
—
312.23
—
- H1 2025
- —
- YTD 2026
- 312.23
- Δ YoY
- —
EBIT
215.03
—
215.03
—
- H1 2025
- —
- YTD 2026
- 215.03
- Δ YoY
- —
EBT
187.28
—
187.28
—
- H1 2025
- —
- YTD 2026
- 187.28
- Δ YoY
- —
Net income
136.67
—
136.67
—
- H1 2025
- —
- YTD 2026
- 136.67
- Δ YoY
- —
EPS (basic)
(PLN)
4.05
—
4.05
—
- H1 2025
- —
- YTD 2026
- 4.05
- Δ YoY
- —
EPS (diluted)
(PLN)
4.15
—
4.15
—
- H1 2025
- —
- YTD 2026
- 4.15
- Δ YoY
- —
D&A
115.86
—
115.86
—
- H1 2025
- —
- YTD 2026
- 115.86
- Δ YoY
- —
Interest expense
32.89
—
32.89
—
- H1 2025
- —
- YTD 2026
- 32.89
- Δ YoY
- —
Income tax
40.9
—
40.9
—
- H1 2025
- —
- YTD 2026
- 40.9
- Δ YoY
- —
Shares (basic)
(m units)
33.76
—
33.76
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBITDA margin
26.46%
—
26.46%
—
- H1 2025
- —
- YTD 2026
- 26.46%
- Δ YoY
- —
EBIT margin
18.22%
—
18.22%
—
- H1 2025
- —
- YTD 2026
- 18.22%
- Δ YoY
- —
Net margin
11.58%
—
11.58%
—
- H1 2025
- —
- YTD 2026
- 11.58%
- Δ YoY
- —
Cash
18.42
—
18.42
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total debt
1,080.64
—
1,080.64
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt
1,203.95
—
1,203.95
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Equity
547.19
—
547.19
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total assets
2,231.88
—
2,231.88
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Working capital
-103.55
—
-103.55
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current assets
455.78
—
455.78
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current liabilities
559.32
—
559.32
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Non-current liabilities
1,145.24
—
1,145.24
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Inventory
57.99
—
57.99
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade receivables
345.84
—
345.84
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade payables
160.36
—
160.36
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Goodwill
652.67
—
652.67
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
CFO
295.1
—
295.1
—
- H1 2025
- —
- YTD 2026
- 295.1
- Δ YoY
- —
CapEx
70.05
—
70.05
—
- H1 2025
- —
- YTD 2026
- 70.05
- Δ YoY
- —
FCF
225.05
—
225.05
—
- H1 2025
- —
- YTD 2026
- 225.05
- Δ YoY
- —
Dividends paid
111.73
—
111.73
—
- H1 2025
- —
- YTD 2026
- 111.73
- Δ YoY
- —
Net acquisitions
41.08
—
41.08
—
- H1 2025
- —
- YTD 2026
- 41.08
- Δ YoY
- —
Current ratio
0.81x
—
0.81x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Quick ratio
0.71x
—
0.71x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Cash ratio
0.03x
—
0.03x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Interest coverage
6.63x
—
6.63x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / equity
2.32x
—
2.32x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / assets
0.55x
—
0.55x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt / equity
2.28x
—
2.28x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Revenue growth (YoY)
14.75%
—
14.75%
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBITDA growth (YoY)
6.97%
—
6.97%
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBIT growth (YoY)
1.45%
—
1.45%
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net income growth (YoY)
2.4%
—
2.4%
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EPS growth (YoY)
2.47%
—
2.47%
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBITDA margin Δ (YoY)
-1.79 pp
—
-1.79 pp
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
EBIT margin Δ (YoY)
-2.11 pp
—
-2.11 pp
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net margin Δ (YoY)
-1.24 pp
—
-1.24 pp
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —